Clinical Trial Update: Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Bryostatin-1 in combination with high-dose cytarabine in patients with refractory or relapsed leukemia or lymphoma; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Bryostatin-1 (bryostatin-1)
• Cytarabine (high-dose) (cytarabine)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED